PD-1 Immunotherapies Induce Painless Thyroiditis in Patients With Metastatic Malignancies
October 31st 2014
Treatment with PD-1 immunotherapy across various oncology clinical trials has been associated with the induction of painless thyroiditis, characterized by transient thyrotoxicosis and hypothyroidism, in patients with metastatic malignancies